Arginine restores T-cell ability to target cancer
Tuesday, November 22, 2011 - 13:31
in Health & Medicine
In many cases, tumors suppress a patient's immune system in a way that keeps the cancer safe from immune system attack. This is particularly true for patients with glioblastoma, a primary brain tumor that carries a prognosis of only 12-15 months survival after diagnosis.